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Abstract
Present studies were performed to examine whether or not the antigen(s) in
infected cells with reovirus type 3, particularly which is distinct from virus capsid
antigen, could be produced when the virus progeny was not detected.
In complement fixation test, the antigens of early extract prepared from infected
cells 1 hour after infection and of purified virus cross-reacted with the antisera
against purified virus (V antiserum) and early extract (E antiserum). It was
suggested that a certain antigenic substance might be contained in both early extract
and purified virus or that the capsid antigen of input virus might be contaminated
in early extract. However, the fluorescent antigen which only reacted with E antiserum,
not with V antiserum appeared in infected cells as early as from 1 to 4 hours after
infection before the appearance of virus capsid antigen. This fluorescent antigen
began to decrease after 10 hours and it was still observed at 20 hours, while, the
virus capsid antigen appeared at 4 hours after infection, and developed continually
during the course of infection.
The effect of actinomycin D or cytosine arabinoside on the development of this
antigen was not essential, although the first appearance was postponed about 3
hours. Puromycin and 6-azauridine completely inhibited the synthesis of this antigen.
This antigen might be coded for virus RNA.
Introduction
Replication of reovirus has been studied
exceedingly on the basis of the genetic
function of virus RNA. Ten segments
of virus genome RNA are copied specif-
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fically into messenger RNA at different
times after infection (Ballamy and Joklik,
1967; Watanabe et al., 1968a). In addi-
tion, RNA polymerase which apparently
transcribes messenger RNA in vitro from
all segments of parent RNA has been
discovered in association with virion
(Borsa and Shatkin, 1968; Shatkin and
Sipe, 1968; Skehel and Joklik, 1969;
Banerjee and Shatkin, 1970). It would
be possible that miscellaneous proteins
other than virus-associated RNA polyme-
rase might be synthesized early in the
infectious cycle for further replication of
virus. Actually, synthesis of 3 species
of virus structural proteins and virusind-
uced RNA polymerase have been demon-
strated individually early in the infectious
cycle (Loh and Shatkin, 1968; Loh and
Oie, 1969; Watanabe et al., 1968b).
However, early events of infectious cycle
have not been examined closely by immu-
nological method.
In this paper, it will be presented that
a new antigenic product in reovirus type
3 infected cells is demonstrated within 1
hour after infection by using indirect
immunofluorescent technique.
Materials and Methods
Cell culture and virus : All cell cultu-
res, stable line of porcine kidney (PS)
cells, HeLa cells and monkey kidney(MK)
cells, were grown in Eagle's basal medi-
umcontaining 10 % bovine serum, 200
unites/ml of penicillin and 120 f/ml of
streptomycin. In maintainance medium,
proportion of serum was decreased to 0.5
persent and calf serum, free from anti-
body against reovirus, was substituted
for bovine serum.
Bearing strain of reovirus type 3 kindly
supplied from Japanese National Institute
of Health. It was propagated four times
in MK cells. The stock virus was pre-
pared from infected PS or HeLa cells.
After removal of culture fluids, infected
cells were scrapped off by rubberpolice-
man, resuspended in maintainance medi-
umin proportion of 107 cells per 1 ml,
and centrifuged at low speed after 3
cycles of freezing and thawing. The
infectivity of the stock virus was given
10 6.5/TCDso Per ml in MK cell mono-
layers.
Infection of cells and the methods for
infectivity, complement fixation and hemag-
glutination test: Well-dispersed PS cells
were infected with the stock virus at the
rate of 3x106 cells per ml of the virus.
The cells were allowed to adsorb the
virus at 37°C for 30 minutes by continuous
gentle shaking. The cells were centri-
fuged, resuspended in maintainance medi-
umcontaining 8 unites of reovirus type 3
antiserum, kept at 37°C for 30 minutes
to neutralize unadsorbed virus. After
washihg the infected cells three times
with Dulbecco's phosphate buffer saline
(PBS pH 7.2), they were refed with the
same volume of maintainance medium,
and incubated at 37°C. At intervals after
infection, the cell-associated virus yielded
from 3xl06 of cells per ml of PBS was
obtained by the method described above
and assayed for infectious, complement
fixing and hemagglutiating activities.
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Infectivity was examined by inoculating
of 0.2 ml of serial dilutions of virus into
each 3 test tube of MK cell cultures.
Cytopathic effect was observed daily for
6 days and the titer of infectivity was
calculated by the method of Reed and
Muench (1938).
Hemagglutination and complement fixa-
tion tests were performed as described by
Rosen, D. (1960) and Pereira, H. G., et
al. (1959) respectively.
Virus purification: Cell associated virus
prepared from infected MK cells was
treated twice with an equal volume of
trichlorotrifluoroethane at room tempera-
ture for 10 minutes. To obtain purified
virus, 1 ml of liquid phase was laid on
the top of CsCl discontinuous gradient
consisted of each 0.8 ml of buoyant den-
sity of 1.580 and 1.430, and 0.5mlof
buoyant density 1.315 in cellulose nitrate
tube, then centrifuged at 39,000 rpm for 4
hours at 4°C in Hitachi SPR-40 swing rot-
or. Eight tenth ml of this cushioned and
concentrated virus (buoyalnt density 1.30
-1.38 g/cm) was recentrifuged in CsCl
linear density gradient at 30,000 rpm for
18 hours at 4°C in the same rotor. Linear
density gradient was prepared by overlay-
ing each 0.7 ml of CsCl at buoyant densi-
ty of from 1.60 to 1.10 in increments of
0.1. CsCl was dissolved in 0.01 M Tris-
HC1 (pH 7.2). Fractions (15 drops each)
were obtained by piercing the bottom of
the tube and dialysed against PBS at 4°C
overnight. The fractions which showed
maximumCF activity were used as the
purified virus.
Preparation of early extracts: MK and
HeLe cells were infected with the stock
virus as described before. One hour after
infection, cells were suspended in PBS
at the rate of 1x107 cells per ml, disrup-
ted by 3 cycles of freezing and thawing,
and centrifuged at 30,000 rpm for 30
minutes at 4°C in Hitachi SPR-40 swing
rotor. The supernatant was used as the
early extract of indected cells and stored
at -75°C until tested. Early extract of
non-infected cells was prepared by the
same method,
Preparation of antisera: Four kinds of
antisera of guinea pigs were prepared
against crude virus, purified virus, and
early extracts of infected and non-infected
MK cells. One tenth ml of antigen was
emulsified in an equal volume of Freund's
complete adjuvant and inoculated into
food-pads of guinea pigs at intervals of
7-10 days three times. Guinea pigs
were bled about 1 week after last inocu-
lation of the vaccine.
Electronmicroscopic examination: PS cell
monolayers in 600 ml culture bottles were
infected with the stock virus to yield the
same infection rate as in the method
described above. At intervals after infec-
tion, infected cells were trypsinized, colle-
cted by low centrifugation, fixed with
glutaldehyde, post fixed with osmium te-
troxide, dehydrated by ethanol and aceton,
and enbeded in epoxin-resin mixture as
the method described by Vasquez, C. and
Tournier, P. (1962). Ultra-thin sections
of this preparations were stained by
ulanyl asetate and lead nitrate.
Fluorescent antibody technique: One day
monolayers of HeLa cells grown on cover-
slips were infected with the stock virus
to yield the same infection rate as in the
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methods described before. At intervals
after infection, 5 replicate coverslips were
sampled and washed three times with
PBS. After air-drying, the samples were
stored at -20°C before tested. The stain
was carried out by using indirect immu-
nofluorescent technique described by Ha-
yashi, K. and Russeil, W. C. (1968).
Anti-metabolites: Actinomycin D (Merk,
Shap and Duhme, Res., Lab, Rahway,
N. L), cytoshine arabinoside (Nut. Bio.
Crop,. Cleveland, Ohio), puromycin(Nut.
Bio. Corp., Cleveland, Ohio), and 6-
azauridine were selected. All drugs were
dissolved in distilled water.
Result
Sequential development of reovirus type 3
antigens in infected PS cells: PS cells infec-
ted with reovirus type 3 was harvested at
intervals after infection and assayed for
infectious, complement fixing (CF) and
hemagglutinating (HA) activities. Elect-
ronmicroscopical studies were also per for-
med to observe the appearance of progeny
viruses in the section of PS infected cells.
Until 4 hours after infection, any pro-
ducts and antigenical substances were not
detected by both thin section of cells and
CF test. As shown in Fig.1, CF antigen
first appeared at 5 hours and reached its
maximumat 8 hours. The appearance of
HA and infectivity was occured at 10
hours, and reached its maximum at 12
hours.
At 5 hours after infection, matrix areas
containing a few shell forms presumed as
inner capsid were first observed in cyto-
plasm in thin sections of infected cells.
At 6 hours, empty shell viruses and
maturing viruses whose center consisted
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Fig. 1. Development of antigens in infected PS cells with reovirus type 3.
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Photo 1. Matrix area produced in cytoplasm of infected PS cells with
reovirus type 3 at 5 hours after infection.
43,200 x magnification.
Photo 2. Matrix area observed in cytoplasm of infected PS cells at
6 hours after infection.
41,000x magnification.
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number as the infection progressed (Pho-
to. 1 and2). The empty shell virus in
the matrix areas was observed throughout
the experiment.
Considering of electronmicroscopical ob-
servations, the infectivity should occure
at 6 hours after infection simultaneously
as well as CF antigen. Both the infecti-
vity and HA, however, were not detected
until 10 hours. This discrepancy might
be due to the assay system for infectivity
in this experiment.
Detection of virus induced product in
early stage of infection by complement
fixation test: Early extracts of infected
MK and HeLa cells were prepared as the
method described before. Early extracts
of non-infected MK and HeLa cells and
of infected HeLa cells with poliovirus
type 1 (Mahoney) were used as controls
of the antigen and antiserum against
early extract of non-infected cells were
also used in CF test for further controls.
As shown in Fig. 2, early extract of
infected HeLa cells reacted with antise-
rumagainst crude virus as well as with
homologous antiserum (E antiserum).
While, crude virus also cross-reacted with
E antiserum. These cross-reactions were
demonstrated at lowest titer by using
even purified virus and its antiserum (V
antiserum). There were no cross-reaction
between control antigens and these antisera
except that between non-infected MK
A ntisera against
A ntigens
E arly extract of Virus antigen
infected
MK cells.
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non-infected
MK cells
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Fig. 2. Box titration of complement fixation test performed by using the early extract
purified virus and their antisera.
The figures mean the titer which was expressed as the reciprocal of dilutions.
The sign of NT shows the cases not tested.
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cells and E antiserum (dilution at 1:4).
Development of two fluorescent antigens
in infected cells: From the result shown
in CF test, it was conceivable that both
the antigens of early extract and purified
virus might contain a certain common
antigenic substance(s) or that the virus
capsid antigen caused by input virus
might be contaminated in early extract
of infected cells. Suppose, one step
curves specifically reacted with E and V
antiserum were obtained respectively, an
antigen which is distinct from virus
capsid antigen studied up to date would
be present in the early extract of infected
cells.
Monolayers of HeLa cell grown on
coverslips were infected with virus as
described before and processed the indi-
rect immunofluorescent method at inter-
vals after infection. Persent of immu-
nofluorescence positive cells was figured
out by counting in total 100 cells under
the fluorescent microscope (Nikon).
One hoar after infection, the specific
fluorescent antigen against E antiserum
was observed in cytoplasm particularly in
the region of cytoplasmic membrane as
dots and flecks, and increased in number
and intensity until 8 hours (Photo. 3).
From 8 to 10 hours, the fluorescence
began to decrease in number and weaken
in intensity but it was still observed at
20 hours. The fluorescent antigen against
V antiserum was first observed in cyto-
plasm at 4 hours as granules in various size,
and reached its maximum from 6 to 8 hours.
It was observed continually even after 20
hours without tendency to decrease as
observed in infected cells stained with
E antiserum (Photo. 4). These findings
seemed to be compatible with appearan-
ces of CF activity and progeny viruses in
thin sections of infected cells as observed
before. The sequential development of
the fluorescent antigen against E and V
antisserum is shown in Fig. 3.
The use of E and V antiserum blocked
with homologous antigen at 4°C overnight
respectively, resulted in no specific fluo-
rescence throughout the experiment. In
addition, the use of antisera blocked with
heterologous antigen was found to have
almost no effect on the development of
the two fluorescent antigens. These
results indicate the presence of an anti-





FA antigen in HeLa cells stained






Photo. 4. FA antigen in HeLa cells stained
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Fig. 3. Development of fluorescent antigens in reovirus type 3 infected HeLa
cells.
0 9 stained with E antiserum serum
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Effect of antimetabolites on the development of fluorescent antigens
against E and V antiserum.
Solid line indicates the development of early product (s) in the
presence of actinomycine D (à"), cytocine arabinoside (x),
puromycine (Q) and 6-azauriaine (A). Dotted line indicates
that of capsid antigens.
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antigen in the early extract of infected
cells.
Effects of antimetabolites on the develop-
ment of early product'. The antigenic
product detected as early as at 1 hour
after infection was characterized with
antimetabolites. Actinomycin D at the
concentration of 20 r/ml, cytosine arabi-
noside 40 r/ml, puromycin 50 r/ml and
6-azauridine 10 r/ml were selected.
Monolayers of HeLa cells grown on
coverslips were pretreated for 1 hour
before infection, and infected with the
virus. The drugs were allowed to contact
with the cells during the experiment.
As shown in Fig. 4, the presence of
actinomycin D or cytosine arabinoside
postponed the first appearance of the
fluorescent antigen against E and V
antiserum about 3 hours. There was,
however, no significant effect on the
development of these antigens was obser-
ved throughout the experiment.
Discussion
Concerning with the development of
reovirus antigen in infected cells, it has
been found that virus capsid antigen
appeared in cytoplasm of infected
cells at 6 to 8 hour after infection by
immunofluorescent method (Rhim et al. ,
1962; Spendlove, et al. 1963). However,
it was not examined whether or not an
early antigenic product, particularly an
antigen which is distinct from virus
capsid antigens, is produced in the early
stage of reovirus infection before the
appearance of virus progeny.
In the present study, the matrix areas
in infected cells and CF activity were
first detected at 5 hour after infection.
Accordingly, early extracts of infected
cells during from 1 to 4 hour after
infection and thier antisera were prepared.
The releiable data were obtained by
using the early extract of infected cells
1 our after infection and its antiserum
(E antiserum). The fluorescent antigen
against E antiserum in infected cells
was observed in cytoplasm as parti-
cular forms of dots and flecks as early
as at 1 hour after infection and developed
considerably before the appearance of the
fluorescent antigen against V antiserum.
From 8 to 10 hours after infection, the
fluorescence began to decrease in number
and in intensity but it was still observed
at 20 hours after infection. These findings
were not observed in poliovirus type 1
infected cells and reovirus infected cells
stained with the antiserum against early
extract of non-infected cells. In addition,
no fluorescent antigen against E and V
antiserum absorbed with homologous
antigen respectively were observed in
infected cells, and there was no signifi-
cant difference betweenthe fluorescent
antigen against V antiserum and that
absorbed with early extract prepared
from the infected cells 1 hour after
infection. Consequently, it may be safely
said that the fluorescent antigen against
E antiserum was distinct from the capsid
antigen.
From the fact of the appearance of
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this product, at least following three
possibilities can ba considered. The first
possibility is that the antigenicity of this
product is due to the remainings of input
virus capsid protein. However, this pos-
sibility seems unlikely, since the fluores-
cence against V antiserum did not demon-
strate in early stage in infected cells but
it was able to detect only against E anti
serum.
Secondly, this product would be an
enzyme which might be essential for
further replication of virus. The last
possibility is that this antigenic product
may be a precursor or a component(s)
of late proteins.
In the studies on early events of reovi-
rus infectious cycle, 3 species of virus
structural proteins and virus-induced RNA
polymerase have been demonstrated indi-
vidually as early as at 1 hour after infec-
tion by using polyacrylamide gel electro-
phoresis (Loh and Shatkin, 1968; Loh
and Oie, 1969; Watanabe et al., 1968b).
Although it is not clear at present whe-
ther or not these early proteins contain
the RNA polymerase, and consist of
three different enzymes, it seems possible
to speculate that the early antigenic
product detected in the present study
might bs or will be one of them.
Generally speaking, reovirus replication
is not inhibited by DNA synthesis inhibi-
tors, cytosine arabinoside etc., but by
RNA synthesis inhibitors, 6-azauridine
and actinomycine D (Gomatos et al.,
1962; Silagi, 1965; Rada and Shatkin,
1967). The appearance of this product
and virus capsid antigens were completely
inhibited by 6-azauridine (at a concentra-
tion of lOfper ml) and puromycin (SOy/
ml), but not by actinomycin D (27-/ml)
and cytosine arabinoside (4(V/ml)although
the first appearance was postponed about
3 hours. In addition, no different beha-
viors against these antimetabolites were
observed between the early product and
virus capsid antigens. Considering these
results, it seems probable that actino-
mycin D or cytosine arabinoside has no
essential effect on the development of
the product detected in the present study
and it would be coded for virus RNA.
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産生は,actinomycine Dや, cytosine arabinosideによって阻止されず(但し,抗原の出現する時間は約
3時間のずれがある.),puromycineや6-azauridineの存在下では完全に阻止された.この事実は,上記の
抗原が,virus RNAによってcodeされたものである事を示唆していると思う.
